Jean-Pierre Tirouflet
No más puestos en curso
Historial de carrera de Jean-Pierre Tirouflet
Antiguos cargos conocidos de Jean-Pierre Tirouflet.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BioSystems International SAS
BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Director Ejecutivo | - | 06/03/2014 |
Altadis SA
Altadis SA TobaccoConsumer Non-Durables Altadis SA engages in the manufacture and distribution of tobacco products. These include cigars and cigarettes. It also offers pipe tobacco and chewing tobacco, and accessories such as rolling paper, cutters, lighters, and storage boxes. The company was founded in 1887 and is headquartered in Madrid, Spain. | Director/Miembro de la Junta | 24/07/2001 | 25/02/2008 |
MEDEF Paris | Presidente | 01/01/2004 | 01/01/2004 |
European Chemical Group Eurochimic
European Chemical Group Eurochimic Household/Personal CareConsumer Non-Durables Part of Ecolab, Inc., European Chemical Group Eurochimic is a French company that manufactures cleaning products. The company is located in France. European Chemical Group Eurochimic was acquired by Laboratoires Anios SAS, part of Ecolab, Inc. from February 01, 2017 on November 01, 1998. | Presidente | - | 01/01/2002 |
European Union
European Union SupranationalGovernment Supranational | Corporate Officer/Principal | 01/01/1978 | 01/01/1980 |
Rhodia Chimie SAS
Rhodia Chimie SAS Chemicals: SpecialtyProcess Industries Rhodia Chimie SAS produces specialty chemicals for food products. The company has partnerships with the automotive, electronic, health and other related sectors. The firm is headquartered in Boulogne-Billancourt, France. | Presidente | - | - |
Presidente | - | - |
Formación de Jean-Pierre Tirouflet.
Ecole Nationale d'Administration | Undergraduate Degree |
Estadísticas
Internacional
Francia | 6 |
España | 2 |
Bélgica | 2 |
Operativa
Chairman | 2 |
President | 2 |
Director/Board Member | 1 |
Sectorial
Consumer Non-Durables | 3 |
Process Industries | 2 |
Government | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 6 |
---|---|
Altadis SA
Altadis SA TobaccoConsumer Non-Durables Altadis SA engages in the manufacture and distribution of tobacco products. These include cigars and cigarettes. It also offers pipe tobacco and chewing tobacco, and accessories such as rolling paper, cutters, lighters, and storage boxes. The company was founded in 1887 and is headquartered in Madrid, Spain. | Consumer Non-Durables |
Rhodia Chimie SAS
Rhodia Chimie SAS Chemicals: SpecialtyProcess Industries Rhodia Chimie SAS produces specialty chemicals for food products. The company has partnerships with the automotive, electronic, health and other related sectors. The firm is headquartered in Boulogne-Billancourt, France. | Process Industries |
European Union
European Union SupranationalGovernment Supranational | Government |
European Chemical Group Eurochimic
European Chemical Group Eurochimic Household/Personal CareConsumer Non-Durables Part of Ecolab, Inc., European Chemical Group Eurochimic is a French company that manufactures cleaning products. The company is located in France. European Chemical Group Eurochimic was acquired by Laboratoires Anios SAS, part of Ecolab, Inc. from February 01, 2017 on November 01, 1998. | Consumer Non-Durables |
BioSystems International SAS
BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Health Technology |
MEDEF Paris |